Sep 08, 2025 11:00
ABP - Abpro Holdings, Inc Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.21 0.0 (-1.78%) | --- | --- | 0.0 (0.58%) | -0.03 (-12.15%) | 0.02 (11.61%) | 0.0 (-0.33%) | 0.0 (-0.33%) |
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.08
- Diluted EPS:
- -0.08
- Basic P/E:
- -2.6163
- Diluted P/E:
- -2.6163
- RSI(14) 1m:
- 50.0
- VWAP:
- 0.21
- RVol:
- 0.778
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 0.21 +0.0 (+1.06%) | Oct 15 17:11 |
| 10m | Price increase 10m | 0.21 +0.01 (+3.09%) | Oct 15 16:59 |
| 1m | Price increase 1m | 0.21 +0.01 (+4.49%) | Oct 15 16:21 |
| 10m | Price increase 10m | 0.21 +0.01 (+4.49%) | Oct 15 16:21 |
| 1m | Price decrease 1m | 0.21 -0.0 (-1.06%) | Oct 15 15:27 |
Related News
Apr 27, 2025 18:00
Mar 10, 2025 22:34